Appointment booking for Dr. Prodromos Angelidis, MD is currently not available.Dr. Prodromos Angelidis, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Prodromos Angelidis, MD (he/him) is a Internist in Tulsa, OK with over 17 years of experience. What is your opinion of Dr. Prodromos Angelidis, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Prodromos Angelidis, MD has received over $1,288 which includes payments from the following companies:
$237.04 from Edwards Lifesciences Corporation
$178.45 from E.R. Squibb & Sons, L.L.C.
$159.96 from Pfizer Inc.
$144.83 from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$133.64 from Janssen Pharmaceuticals, Inc
$103.57 from Novo Nordisk Inc
$85.83 from sanofi-aventis U.S. LLC
$62.12 from Merck Sharp & Dohme Corporation
$49.57 from Novartis Pharmaceuticals Corporation
$31.99 from AstraZeneca Pharmaceuticals LP
$23.48 from Mallinckrodt LLC
$20.59 from Salix Pharmaceuticals, Ltd
$17.31 from Abbott Laboratories
$16.98 from Salix Pharmaceuticals, a division of Bausch Health US, LLC
$12.07 from UCB, Inc.
$11.53 from Theravance Biopharma Inc.
Payments received by Dr. Prodromos Angelidis, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!